ABSTRACT
@#Low contraceptive uptake among men remains significant issues in Indonesia. Hence, this study seeks to understand the association between socio-demographic factors and men’s contraceptive use in Indonesia by utilizing the 2012 Indonesia Demographic and Health Survey (IDHS), couple dataset. Bivariate analysis was conducted by performing a chi-squared test of independence to analyse the relationship between selected socio-demographic factors and the dependent variable. A binary logistic regression model was considered to identify the effects of covariates. Place of residence, husbands’ approval on family planning, husbands and wives knew family planning from newspaper/magazine, and the perception that contraception is woman’s business were significant predictors according to the IDHS. Programs related to gender-sensitive campaign about family planning and gender-sensitive curricula in schools are needed for encouraging men to use contraception.
ABSTRACT
A lo largo de la historia las mujeres han sido las responsables de la reproducción biológica, han cargado mayormente con la responsabilidad de la anticoncepción (1); surge la necesidad de incorporar a hombres en salud reproductiva con métodos modernos, efectivos y reversibles, como la Píldora Anticonceptiva Oral Masculina, que se encuentra en fase II de investigación, y así participar activamente en la planificación familiar. OBJETIVO: Establecer la relación entre el conocimiento e intención de uso de la Píldora Anticonceptiva Oral Masculina, en varones en edad fértil de una Universidad del Sur de Chile, durante segundo semestre del 2018. MATERIAL Y MÉTODO: Investigación Cuantitativa, correlacional, no experimental y transversal, en 301 estudiantes regulares, se autoadministra instrumento: "Encuesta Anticonceptivos Orales en Varones en Edad Fértil", validado por medio de comité de expertos, con Coeficiente de Alpha de Cronbach de 0,81. RESULTADOS: Respecto al nivel de conocimiento acerca de la Píldora, sólo un 16% tuvo un puntaje mayor o igual a 17 puntos considerándose como alto conocimiento. Respecto de intención de uso, un 58% de los estudiantes varones tiene una alta intención de uso, además de que el 42% estaría dispuesto a utilizar este método anticonceptivo de forma diaria. CONCLUSIÓN: No existe una relación entre el nivel de conocimiento y la intención de uso de la píldora, pues independiente del nivel de conocimiento siempre se mantuvo una alta intención de uso investigación y así participar activamente en la planificación familiar
Throughout history, women have been responsible for biological reproduction, they have been mostly responsible for contraception (1); There is a need to incorporate men into reproductive health with modern, effective and reversible methods, such as the Male Oral Contraceptive Pill, which is in phase II of research, and thus actively participate in family planning. OBJECTIVE: To establish the relationship between the knowledge and intention to use the Male Oral Contraceptive Pill, in men of childbearing age of a University of Southern Chile, during the second half of 2018. MATERIAL AND METHOD: Quantitative, correlational, non-experimental research and Transversal, in 301 regular students, self-administered instrument: "Survey of Oral Contraceptives in Men of Fertile Age", validated through an expert committee, with Cronbach's Alpha Coefficient of 0.81. RESULTS: Regarding the level of knowledge about the Pill, only 16% had a score greater than or equal to 17 points, considered ashigh knowledge. Regarding intention to use, 58% of male students have a high intention to use, in addition to 42% would be willing to use this method of contraception on a daily basis. CONCLUSION: There is no relationship between the level of knowledge and the intention to use the pill, because independent of the level of knowledge, a high intention to use research was always maintained and thus actively participate in family planning.
Subject(s)
Humans , Male , Child , Adolescent , Adult , Young Adult , Students , Health Knowledge, Attitudes, Practice , Contraceptive Agents, Male , Chile , Cross-Sectional Studies , Intention , Family Development Planning , Family Planning ServicesABSTRACT
Infertility affects nearly 15 per cent of all couples within the reproductive age worldwide, with about 50 per cent being exhibited in the male, called male factor infertility. Successful reproduction is dependent on sperm chromatin integrity. Spermatozoa are highly specialized cells that aim to transmit the paternal genomic blueprint to the oocyte. The spermatozoon is regulated by redox mechanisms during its epididymal transit to acquire fertilizing ability. While, at physiological levels, the production of reactive oxygen species (ROS) supports the spermatozoon to acquire its fertilizing ability, at high concentrations, it affects sperm function leading to infertility. Emerging proteomic technologies provide an opportunity to address these key issues that may solve many fertility-associated problems resulting from oxidative stress (OS). This review highlights the need for an efficient therapeutic approach to male infertility with the application of high-throughput OS-mediated proteomic technology, and also addresses the question as to whether targeting these altered sperm-specific proteins may help in designing an efficient and reversible male contraceptive.
ABSTRACT
The aim of hormonal male contraception is to prevent unintended pregnancies by suppressing spermatogenesis. Hormonal male contraception is based on the principle that exogenous administration of androgens and other hormones such as progestins suppress circulating gonadotropin concentrations, decreasing testicular Leydig cell and Sertoli cell activity and spermatogenesis. In order to achieve more complete suppression of circulating gonadotropins and spermatogenesis, a progestin has been added testosterone to the most recent efficacy trials of hormonal male contraceptives. This review focusses on the potential effects of male hormonal contraceptives on cardiovascular risk factors, lipids and body composition, mainly in the target group of younger to middle-aged men. Present data suggest that hormonal male contraception can be reasonably regarded as safe in terms of cardiovascular risk. However, as all trials have been relatively short (< 3 years), a final statement regarding the cardiovascular safety of hormonal male contraception, especially in long-term use, cannot be made. Older men with at high risk of cardiovascular event might not be good candidates for hormonal male contraception. The potential adverse effects of hormonal contraceptives on cardiovascular risk appear to depend greatly on the choice of the progestin in regimens for hormonal male contraceptives. In the development of prospective hormonal male contraception, data on longer-term cardiovascular safety will be essential.
ABSTRACT
The aim of hormonal male contraception is to prevent unintended pregnancies by suppressing spermatogenesis. Hormonal male contraception is based on the principle that exogenous administration of androgens and other hormones such as progestins suppress circulating gonadotropin concentrations, decreasing testicular Leydig cell and Sertoli cell activity and spermatogenesis. In order to achieve more complete suppression of circulating gonadotropins and spermatogenesis, a progestin has been added testosterone to the most recent efficacy trials of hormonal male contraceptives. This review focusses on the potential effects of male hormonal contraceptives on cardiovascular risk factors, lipids and body composition, mainly in the target group of younger to middle-aged men. Present data suggest that hormonal male contraception can be reasonably regarded as safe in terms of cardiovascular risk. However, as all trials have been relatively short (< 3 years), a final statement regarding the cardiovascular safety of hormonal male contraception, especially in long-term use, cannot be made. Older men with at high risk of cardiovascular event might not be good candidates for hormonal male contraception. The potential adverse effects of hormonal contraceptives on cardiovascular risk appear to depend greatly on the choice of the progestin in regimens for hormonal male contraceptives. In the development of prospective hormonal male contraception, data on longer-term cardiovascular safety will be essential.
Subject(s)
Humans , Male , Age Factors , Androgens/therapeutic use , Antispermatogenic Agents , Cardiovascular Diseases/epidemiology , Contraceptive Agents, Male/therapeutic use , Gonadotropins/metabolism , Progestins/therapeutic use , Testosterone/therapeutic useABSTRACT
Measurement of intratesticular sex steroid concentrations in men informs both the development of male hormonal contraceptives and the understanding of male infertility. Given the challenges of using invasive techniques to measure testicular hormone physiology, our group has used a minimally-invasive fine-needle aspiration technique to measure intratesticular hormones in normal healthy men. Herein, we present a post-hoc analysis of the safety and efficacy of testicular fine-needle aspiration (FNA) completed as part of six clinical trials. From 2001 through 2011, a total of 404 procedures were conducted among 163 research volunteers, 85.9% of which were successful in obtaining sufficient fluid for the measurement of intratesticular steroid concentrations. Pain was the most common side effect, with 36.8% of procedures associated with moderate procedural pain and 4.7% with severe procedural pain. Postprocedural pain was uncommon and abated within a few days. Mild local bruising occurred with 14.9% of procedures. Two serious adverse events (0.5%) required surgical intervention. The risk of an adverse event was not associated with age, body mass index, testicular size, or the volume of fluid aspirated. Testicular FNA to obtain fluid for measurement of intratesticular steroid concentrations frequently causes mild to moderate procedural pain, but serious adverse events occur rarely. Testicular FNA has been instrumental for defining human intratesticular hormone physiology and is a minimally-invasive, safe, effective method for obtaining fluid for research on testicular physiology and pathology.
ABSTRACT
We have investigated the feasibility of administration of testosterone undecanoate (TU)-loaded injectable in situ-forming implant (ISFI) for contraception in adult male Sprague-Dawley rats. Male rats were treated with vehicle, TU-loaded ISFIs (540, 270 and 135 mg TU kg-1 ) or TU injections (45 mg TU kg-1 every 30 days) for 120 days. Fertility tests served for determining infertility or restoration of fertility in treated rats. Serum testosterone concentration, epididymal sperm count, motility, morphology, and histology of the testis were monitored. The TU-loaded ISFIs increased serum testosterone levels in rats steadily without fluctuation over 3 months. One month after TU administration, the epididymal sperm count decreased significantly in all experimental groups. After 3 months, the animals treated with 270 and 135 mg kg-1 TU-loaded ISFIs were 100% infertile, and no implantation sites were produced in the mated females. However, some of males treated with 540 mg kg-1 ISFI or TU injections were still fertile but numbers of implantation sites were also significantly lower than control values. TU-loaded ISFI at an appropriate dose has potential as a long-acting male contraceptive drug that suppresses spermatogenesis consistently over a period of 3 months.
ABSTRACT
Over the last two decades RISUG has been drawing attention in the field of male contraception. It promises to sterile men for a period of up to 10-15 years. According to recent studies in animal models, it proves to be completely reversible. Practically, there are no better options available that can assure complete sterility and precise reversibility. Regardless of so much of information available, RISUG is still holding up for many reasons, firstly, the available information engender bewilderment such as what is this copolymer, how does it work and is reversal really possible? Secondly, advancement of this outstanding invention is drastically slow and thirdly, effects of long-term contraception with RISUG and reports on evaluation of anomalies (if any) in F1, F2 progenies, are lacking. In this review the lacunae as well as advances in the development of RISUG in the light of published work and available resources are pointed out. Formulation of the RISUG, its mode of action and clinical trials have been addressed with particular emphasis.
ABSTRACT
Contraception is a basic human right for its role on health, quality of life and wellbeing of the woman and of the society as a whole. Since the introduction of female hormonal contraception the responsibility of family planning has always been with women. Currently there are only a few contraceptive methods available for men, but recently, men have become more interested in supporting their partners actively. Over the last few decades different trials have been performed providing important advances in the development of a safe and effective hormonal contraceptive for men. This paper summarizes some of the most recent trials.
ABSTRACT
Aims: To investigate the effects of methanolic extract of Citrullus lanatus seed (MECLS) on experimentally induced benign prostate hyperplasia. Study design: Animal model of experimentally induced prostatic hyperplasia. Place and Duration of Study: Department of Anatomy, Faculty of Basic Medical Sciences, Ikenne Campus, Ikenne, Ogun State, Nigeria, between May 2010 and August 2010. Methodology: Twenty adult male Wistar rats weighing about 135-180g were randomly divided into four groups of five animals each. Group I, Normal control (NC) was given corn oil as placebo 1g/Kg BW; Group II, Hormone treated control (HTC), Groups III, and IV hormone and extract treated (HTEC), received continuous dosage of 300μg and 80μg of testosterone (T) and estradiol (E2) respectively on alternate days for three weeks subcutaneously in the inguinal region while the extract treated received an additional 2g/Kg BW (low dose) and 4g/Kg BW (high dose) of extract orally for 4 weeks after the successful induction of prostate enlargement. Immediately after induction some animals were randomly selected and sacrificed for gross inspection of prostate enlargement and sperm count evaluation, these procedures were repeated again after four weeks of extract treatment. Portion of the prostate were taken and processed routinely for paraffin embedding and stained with H&E. Results: Hormone treatment did not affect the body weight of the animals; however it caused a significant decrease in the weight of the testes and rendered all the rats azoospermia. In addition, treatment with extracts caused a significant decrease in the enlarged prostate, seminal vesicle and testes sizes in a dose related manner (P<0.05) compared to the hormone treated control. Histological examination of prostate revealed that the methanolic extract caused significant changes in its histo-architecture. There was an increase in the fibromuscular layer, decrease in prostatic acini size, shrinkage of epithelium, and no infolding of the epithelium into the lumen, rather, it appeared flat compared to the very distinct columnar epithelium of the hormone treated control and conspicuousness of the acini. The extracts further caused a dose dependent reduction in the prostates weight. PSA level was significantly lowered in both HTEC at low and high doses (P<0.05) in dose dependent manner. Conclusion: Administration of MECLS for one month reduced the prostate size significantly (P< 0.05), both at high and low dose, but could not restore the initial size of shrunken testes and severe oligospermia caused by the hormones. The histological studies clearly establish MECLS as a potential candidate in management of androgen dependent conditions like benign prostate hyperplasia.
ABSTRACT
Biological and clinical research on male reproduction and fertility regulation carried at the National Institute of Health and Family Welfare over the past 17 years has been highlighted in this review. Areas of research covered pertains to hormones in relation to sperm maturation and transport; fertilizing ability of spermatozoa under different experimental conditions; agents producing functional sterility; seasonal variations in primate reproduction; male infertility including semen biochemistry, differential diagnosis between obstructive and non-obstructive azoospermia and hormone therapy; vasectomy, reversible vasocclusion and vasanastomosis; and the use of cyproterone acetate and testosterone enanthate in male rhesus monkey and human volunteers for reversible contraception.